Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

In Brief: GATT patent extensions

Executive Summary

GATT patent extensions: U.S. Patent and Trademark Office should withdraw its final determination published in the Federal Register June 7 stating that Waxman/Hatch Sec. 156 extensions will not be added on top of the new 20-year patent terms enacted in the Uruguay Rounds Agreement Act, according to a June 12 letter to PTO Commissioner Bruce Lehman from Pharmaceutical Research & Manufacturers of America President Gerald Mossinghoff. PhRMA maintains that the PTO's argument for the several meanings of "original expiration date" is flawed because the "term appears only once in the entire patent statute" and simply refers to the date of expiration before a Waxman/Hatch extension is granted ("The Pink Sheet" June 12, p. 9)...
Advertisement
Advertisement
UsernamePublicRestriction

Register

PS026376

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel